Health Velocity Capital adds Welborn to advisory board

Health Velocity Capital has named Sally Welborn to its advisory board. Recently, Welborn worked at Walmart Stores Inc where she was senior vice president of global benefits.


San Francisco, CA and Nashville, TN – Health Velocity Capital, one of the nation’s leading healthcare venture and growth capital firms, is pleased to announce the appointment of Sally Welborn to its Advisory Board.

Ms. Welborn was most recently Senior Vice President of Global Benefits for Walmart Stores, Inc. where she was responsible for overseeing the global benefits programs for more than 2.2 million Walmart associates and their families in twenty-eight countries.

Prior to joining Walmart, Ms. Welborn was Senior Vice President, Corporate Benefits for Wells Fargo & Company. She has also held positions at HCIA, William M. Mercer Inc., and Aetna. She currently serves on the Board of Directors of Truveris and the Leapfrog Group and as a Board Advisor for the Penn Center for Health Incentives and Behavioral Economics. She was previously on the Board of the National Business Group on Health. In her roles at Walmart and Wells Fargo, Ms. Welborn was among the nation’s early adopters of defined contribution health benefits, centers of excellence, narrow networks, cost transparency, telemedicine, and second opinion services.

According to Bruce Crosby, Managing Partner of Health Velocity Capital, “We are very pleased to have Sally join our team. She shares a passion for our mission, which is to support the nation’s leading healthcare software and services innovators focused on a more cost-effective, sustainable, and consumer friendly healthcare system and brings a wealth of experience in consistently identifying and partnering with innovators who can help achieve this mission. She will be invaluable to our portfolio companies, our diligence efforts, and our network of strategic investors.”

About Health Velocity Capital
Health Velocity Capital invests exclusively in innovative healthcare software and services companies. The firm’s partners have more than 50 collective years as investors, entrepreneurs and senior executives helping to build innovative companies that created important new healthcare markets and/or that became market leaders, including companies such as Teladoc, Change Healthcare, US Renal Care, Aperio, Aspire Healthcare, The Advisory Board Company, Healthways (Tivity Health), MDLive, Infusion Express, Spero Health, OnShift, Vantage Oncology, D2Hawkeye, Compassus, iTriage, Contessa Health, Livongo, Circulation Health and many others. In addition to investing on behalf of institutional investors, Health Velocity invests on behalf of a number of our nation’s largest and most influential healthcare organizations and many of their top executives who collectively represent organizations that provide health insurance to more than 140 million Americans, operate almost 300 hospitals, provide pharmacy and PBM services to more than 75% of all Americans, and provide software and services to every major hospital in the United States. For more information, please visit